160 related articles for article (PubMed ID: 31674066)
1. Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
Favaloro EJ
Am J Hematol; 2020 Jan; 95(1):117-128. PubMed ID: 31674066
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
[TBL] [Abstract][Full Text] [Related]
3. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
4. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
5. Lupus anticoagulant assays: questions answered and to be answered.
Teruya J; West AG; Suell MN
Arch Pathol Lab Med; 2007 Jun; 131(6):885-9. PubMed ID: 17550315
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant: case-based external quality assessment.
van den Besselaar AM; Devreese KM; de Groot PG; Castel A
J Clin Pathol; 2009 Aug; 62(8):731-4. PubMed ID: 19638545
[TBL] [Abstract][Full Text] [Related]
7. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
Ieko M; Naito S; Yoshida M
Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
[TBL] [Abstract][Full Text] [Related]
8. To mix or not to mix in lupus anticoagulant testing? That is the question.
Tripodi A
Semin Thromb Hemost; 2012 Jun; 38(4):385-9. PubMed ID: 22618530
[TBL] [Abstract][Full Text] [Related]
9. Lupus-anticoagulant testing at NOAC trough levels.
Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
[TBL] [Abstract][Full Text] [Related]
10. Mixing studies for abnormal coagulation screen - the current trend.
Mohammad E; Thachil J
Clin Chem Lab Med; 2017 Mar; 55(3):e54-e55. PubMed ID: 27522100
[No Abstract] [Full Text] [Related]
11. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
[TBL] [Abstract][Full Text] [Related]
12. [Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].
Morinaga S; Ide Y; Kusumoto M; Ogata M; Takaki K; Matsumoto E
Rinsho Ketsueki; 2012 Jul; 53(7):716-20. PubMed ID: 22975775
[TBL] [Abstract][Full Text] [Related]
13. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
[No Abstract] [Full Text] [Related]
14. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.
Kershaw G; Orellana D
Semin Thromb Hemost; 2013 Apr; 39(3):283-90. PubMed ID: 23457048
[TBL] [Abstract][Full Text] [Related]
15. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
[TBL] [Abstract][Full Text] [Related]
16. Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.
Li R; Swaelens C; Vandermijnsbrugge F; Cantinieaux B
Eur J Haematol; 2016 Jun; 96(6):578-85. PubMed ID: 26179977
[TBL] [Abstract][Full Text] [Related]
17. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
18. Laboratory testing for lupus anticoagulants: a review of issues affecting results.
Tripodi A
Clin Chem; 2007 Sep; 53(9):1629-35. PubMed ID: 17712001
[TBL] [Abstract][Full Text] [Related]
19. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
[TBL] [Abstract][Full Text] [Related]
20. Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa.
Favaloro EJ; Gilmore G; Arunachalam S; Mohammed S; Baker R
Thromb Res; 2019 Aug; 180():10-19. PubMed ID: 31158643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
